期刊文献+

异体外周血造血干细胞移植治疗白血病的研究 被引量:8

STUDY ABOUT ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN THE TREATMENT OF LEUKEMIA
下载PDF
导出
摘要 报告用HLA相合的同胞异基困外周血造血干细胞移植治疗白血病3例,1例为CML-CP,1例为ALL-CR1,1例为AML-M2CR1,预处理方案均为环磷酰胺60mg/kg×2天,全身60Co照射4Gy×3天,供者于-5日起间步每日给予G-CSF5μg/kg,-5日后即-1日用BaxerCS3000血细胞分离机分离单个核细胞(MNC)其MNC为7.70、3.44及2.46×108/kg,LD34+细胞为25.7及19.2×106/kg,CD34+/CD33-细胞为1.11及0.59×106/kg,CD3+细胞为94.9及136.8×106/kg,血循环量为10升分离后给思考静脉输注(在TBI4小时以后).次日(0日)再分离一次MNC输注给病人,认为Allo-PBSCT可以使造血细胞植入恢复得快,感染及出血的机会减少,抗菌素的使用天数减少,急性GVHD并不增多、对Allo-PBSCT的有关问题讨论。 We reported three patients with leukemia transplanted with allogeneic peripheralblood stem cells of HLA matchcd siblings. They are a man with CML in chronic phasc, a femalewith ALL in CR1 and a man with AML in CR1. All of them were transplanted with HLAidentical siblings' Allo-PBSC. After conditioned with CTX 60mg/kg×2 and TBI 4.0Gy×3,themononouclear cell which were collected by leukophereses,(Baxter CS3000 101 ) were infusedwithout cryoprcscrvation for two times. The NMC infused, in cascs 1,2 and 3 were 7.70,3.44and 2.46×108/kg respectively. The CD34+, CD34+/CD33- and CD3+ cells infused were 78.3and 21.1,30.1 and 20.0,94.9 and 136.8 ×106/kg respectively in case 2 and case 3.Thehacmopoiesis recovery was much faster than that of the BMT group. Acute GVHD of grade Ⅱ、Ⅰand Ⅲ occured in cases 1.2 and 3 respcctivcly.All of them wcre controlled by prednisolone.We reviewed some reports of Allo-PBSCT and concluded that Allo-PBSCT are the alternativesource of stem cells of transplantation. Patients with Allo-PBSCT has a faster recovery ofleukocy te and platelet than with bone marrow transp lantation, Patients with Allo-PBSCT haveless risk of infection and hemorrhage, and reduced thC need of blood prcduct support.
出处 《白血病》 1996年第2期66-69,共4页
关键词 造血干细胞 移植 白血病 ALL0-PBSCT Allo-PBSCT Luekemia
  • 相关文献

同被引文献28

  • 1温丙昭,哈丽代.骨髓移植合并出血性膀胱炎的预防[J].中华血液学杂志,1993,14(11):592-592. 被引量:1
  • 2温丙昭,张吉仙,哈丽代,付美兰,李向荣,张缙鸾.MTX、Pred、CsA、Aza方案预防GVHD的临床研究[J].中华血液学杂志,1996,17(4):217-218. 被引量:6
  • 3王吉耀 林果为 等.临床经济学评价.现代临床流行病学[M].上海:上海医科大学出版社,2000.126-139.
  • 4Kessinger A,Smith DM,Strandjord SE,et al.Allogeneic transplantation of blood-derived,T cell-depleted hemopoietic stem cells after myeloablative treatment in a patiet with acute lymphoblastic leukemia.Bone Marrow Transplant.1998,4:643-646.
  • 5Bensiger WI,Clift R,Martin P,et al.Allogeneic peripheral blood stem cell transplanation in patiets with advanced hematologic malignancies:a retrospective comparison with marrow transplantation.Blood,1996,88:2794-2799.
  • 6Russel JA,Brown,T,Brown C,et al.Allogeneic blood transplants for hematological malignancy:comparison of engraftment ant graftverses-host disease with bone marrow transplantation.Bone Marrow Tranaplant.1996,17:703-708.
  • 7LX Cao,LD Hu,Chen,et al.Allogeneic peripheral blood stem cell transplantation in the treatment of leukemia in China.Bone Marrow Tranaplantation.1997,19:403-404.
  • 8Champlin R,Schmitz N,Mary M,et al.Blood stem stem cella compared with bone marrow an a source of hematopoietic cells for allogeneic tranaplantation.Blood,2000,95:3702-3709.
  • 9曹履先,骨髓移植,1994年,108页
  • 10温丙昭,中华血液学杂志,1992年,13卷,11期,549页

引证文献8

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部